國家衛生研究院 NHRI:Item 3990099045/8821
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 906544      在线人数 : 981
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8821


    题名: Depleting macrophage or blocking cell fusion machinery ameliorates intestine fibrosis after radiation
    作者: Chang, YH;Ch'ang, HJ;Lin, LM
    贡献者: National Institute of Cancer Research
    摘要: Purpose: Delayed radiation enteritis is a frequent side effect of abdominal radiotherapy. Recent studies reveal bone marrow (BM) cells repopulate damaged tissue and contribute to repair in non-hematopoietic tissues. Fusion between BM and somatic cells is enhanced by chronic inflammation. Furthermore, BM cells (BMC) can trigger fibrotic response in damaged organ. The role of cell fusion in the development of chronic intestine fibrosis after radiotherapy needs further investigation. Materials and Methods: To evaluate cell fusion and fibrosis, gender-mismatched BM transplantation (BMT) were used. Immunoblots of macrophage fusion receptor (MFR), CD47 and fibronectin, connective tissue growth factor (CCN2) were measured. BMT with CD11b (+), CD3 (+) or B220 (+) enriched BMC were applied. The mice were treated with macrophage depleting agents, clodronate liposome, after radiotherapy and BMT. In vitro co-culture study of human intestine stromal and mouse BMC was established. Furthermore, we used Rac 1 inhibitor, MMP9 neutralizing antibody and siRNA of MFR within co-culture system and animal model. Results: Using triple stains of Y chromosome fluorescence in situ hybridization, GFP and hematopoietic cell markers including F4/80, CD3, B220, we found BM derived macrophages contributed majorly to cell fusion (63.4%, 47.5% and 9.6%, respectively, p=0.033) within intestine of mice after radiotherapy and BMT. The fusion within intestine decreased 57% after treatment with clodronate liposome. BMT from CD11b(+), CD3(+) or B220(+) enriched donor BMC also revealed prominent fusion only in mice receiving CD11b(+) one. The level of intestine fibrosis was decreased by clodronate liposome or BMT of CD11b(-) BMC. In vitro study showed the rate of fusion decreased from 12.8% to 6.8% between intestine stromal cells with CD11b (-) compared to that with whole mouse BMCs. Fusion rate could be increased by increasing CD11b(+) BMCs (3.5% to 19.7%). Using Rac1 inhibitor, MMP9 antibody or MFR siRNA, the fusion rate decreased (19.7% to 4.6%; 11.8% to 5.6%; 31% to 19.6%, respectively). The expression of fibronectin, CCN2, MFR and CD47 paralleled the findings of fusion. Using MMP9 neutralizing antibody in mice receiving radiotherapy and BMT, we found decreased cell fusion and fibrosis within intestine. Conclusions:BM derived CD11b(+) myelomonocytic cells or macrophage contribute majorly to cell fusion and fibrosis within intestine of mice after radiotherapy Depleting macrophage or targeting cell fusion machinery of macrophage suppresses intestine fibrosis after radiotherapy. Our study impacts not only for developing novel therapies to prevent radiation enteritis but also to avoid fibrosis after BM cell therapy in organ dysfunction.
    日期: 2014-10
    關聯: Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 3959.
    Link to: http://dx.doi.org/10.1158/1538-7445.am2014-3959
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0008-5472&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000349910201443
    显示于类别:[常慧如] 會議論文/會議摘要

    文件中的档案:

    没有与此文件相关的档案.



    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈